1. Home
  2. TRDA vs CDZI Comparison

TRDA vs CDZI Comparison

Compare TRDA & CDZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$14.02

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Logo CADIZ Inc.

CDZI

CADIZ Inc.

HOLD

Current Price

$4.69

Market Cap

413.8M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRDA
CDZI
Founded
2016
1983
Country
United States
United States
Employees
N/A
31
Industry
Biotechnology: Pharmaceutical Preparations
Water Supply
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
481.6M
413.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TRDA
CDZI
Price
$14.02
$4.69
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$21.00
N/A
AVG Volume (30 Days)
162.5K
493.1K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$25,421,000.00
N/A
Revenue This Year
$39.97
$23.80
Revenue Next Year
$50.80
$125.51
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.93
$2.45
52 Week High
$14.36
$6.96

Technical Indicators

Market Signals
Indicator
TRDA
CDZI
Relative Strength Index (RSI) 61.47 40.77
Support Level $10.84 $4.46
Resistance Level N/A $5.81
Average True Range (ATR) 0.75 0.25
MACD 0.12 -0.00
Stochastic Oscillator 87.79 8.40

Price Performance

Historical Comparison
TRDA
CDZI

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About CDZI CADIZ Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, generating maximum revenue engaged in providing water filtration solutions for impaired or contaminated groundwater sources.

Share on Social Networks: